Low Grade Astrocytoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Low Grade Astrocytoma

subtype

Identifier: CI-CAN-00005775
Entity page: /cancer/low-grade-astrocytoma ↗
Edges: 106

Neighbours: 36 drugs10 trials
Drawn: 46 of 46 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Low Grade Astrocytoma investigated in trials for …INVESTIGATED_IN_TRIALSderived36 of 36show fewer
→ investigated in trials for	Temozolomidesmall molecule 10 trials (5 active) · roll-up of the cancer and its descendants	—	—	Low Grade Astrocytoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants

Low Grade Astrocytoma studied in …STUDIED_INderived10 of 70show all (up to 200)
→ studied in	NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ALIAS · 70 trials mapped (23 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Diffuse Astrocytoma, IDH-Wildtype	1	Observed	clinicaltrials	graph →
→ studied in	NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT01089101Phase 1/Phase 2 · active not recruiting Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma · condition mapped CURATED_BROADER · 70 trials mapped (23 active)	—	—	Childhood Pilocytic Astrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04065776NA · active not recruiting Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Pilocytic Astrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04166409Phase 3 · recruiting A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Low Grade Astrocytoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 70 trials mapped (23 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT03975829Phase 4 · active not recruiting Pediatric Long-Term Follow-up and Rollover Study · condition mapped CURATED_BROADER · 70 trials mapped (23 active)	—	—	Diffuse Astrocytoma	1	Observed	clinicaltrials	graph →